BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18617063)

  • 1. Association of inv(3)(q21q26) with essential thrombocythemia in transformation.
    Villalón C; Talavera M; Sordo MT; García-Sagredo JM; Lopez J; San Román C; Ferro MT
    Cancer Genet Cytogenet; 2008 Jul; 184(2):122-3. PubMed ID: 18617063
    [No Abstract]   [Full Text] [Related]  

  • 2. [Essential thrombocythemia in transformation from myelodysplastic syndrome to acute myeloid leukemia with inv(3) after treatment for gastric cancer].
    Horikoshi M; Machida U; Itikawa M; Seo S; Masuda S; Kurokawa M; Ogawa S; Sunaga S; Honda H; Aoki K; Chiba S; Mitani K; Hirai H; Yazaki Y
    Rinsho Ketsueki; 2000 Jan; 41(1):68-71. PubMed ID: 10695403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An acute leukemia case with complex karyotype abnormalities and marked thrombocythemia].
    Okamura T; Hayakawa H; Sumida I; Hanada M; Nakasato S; Takeshita M; Ohgami A; Kikuchi M; Kamada N
    Rinsho Ketsueki; 1987 Nov; 28(11):2023-8. PubMed ID: 3482113
    [No Abstract]   [Full Text] [Related]  

  • 4. Acquired inv(9): what is its significance?
    Betz JL; Behairy AS; Rabionet P; Tirtorahardjo B; Moore MW; Cotter PD
    Cancer Genet Cytogenet; 2005 Jul; 160(1):76-8. PubMed ID: 15949575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mutant CALR allele burden in essential thrombocythemia at transformation to acute myeloid leukemia.
    Langabeer SE; Haslam K; Elhassadi E
    Blood Cells Mol Dis; 2017 Jun; 65():66-67. PubMed ID: 28552475
    [No Abstract]   [Full Text] [Related]  

  • 6. Double Inv(3)(q21q26), a rare but recurrent chromosomal abnormality in myeloid hemopathies.
    De Braekeleer E; Douet-Guilbert N; Le Bris MJ; Ianotto JC; Berthou C; Gueganic N; Bovo C; Basinko A; Morel F; De Braekeleer M
    Anticancer Res; 2013 Feb; 33(2):639-42. PubMed ID: 23393360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of acute myeloid leukemia associated with Ph-negative clone with inv(3)(q21q26) during imatinib therapy for chronic myeloid leukemia.
    Dvorak P; Hruba M; Subrt I
    Leuk Res; 2009 Jun; 33(6):860-1. PubMed ID: 18977531
    [No Abstract]   [Full Text] [Related]  

  • 8. Paracentric inv(3)(q21q26) in acute myeloblastic leukemia (M2) with normal thrombopoiesis.
    Sundareshan TS; Augustus M; Yasha TC; Devi VL; Bapsy PP
    Cancer Genet Cytogenet; 1992 Mar; 59(1):93-4. PubMed ID: 1555199
    [No Abstract]   [Full Text] [Related]  

  • 9. Disappearance of JAK2 V617F mutation in a rapid leukemic transformed essential thrombocythemia patient.
    Hsiao HH; Yang WC; Liu YC; Lee CP; Lin SF
    Leuk Res; 2008 Aug; 32(8):1323-4. PubMed ID: 18078991
    [No Abstract]   [Full Text] [Related]  

  • 10. inv (4)(p13q13) in patient with essential thrombocythemia: A case report.
    Aydin C; Salim O; Yucel OK; Undar L; Karauzum SB
    Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):181-4. PubMed ID: 25953232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Essential thrombocythemia transformed to acute myeloblastic leukemia].
    Okuda M; Shishido T; Sato A; Nagai T; Sugawara T; Kameoka J; Kaneda K; Meguro K; Fukuhara O; Sakurai T
    Rinsho Ketsueki; 1990 Oct; 31(10):1689-93. PubMed ID: 2255058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonality analysis of cell lineages in acute myeloid leukemia with inversion 16.
    Chang H; Nayar R; Li D; Sutherland DR
    Cancer Genet Cytogenet; 2005 Jan; 156(2):175-8. PubMed ID: 15642400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insertion (4;11)(q27;q24q21) in a patient with essential thrombocythemia with progression to myelofibrosis.
    Gargallo P; Hagemeijer A; Vassallu P; Kornblihtt L; Heller P; Molinas F; Larripa I
    Cancer Genet Cytogenet; 2004 Oct; 154(1):72-6. PubMed ID: 15381377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocation(X;2)(q26;q11.2) in a patient with acute myeloid leukemia M2 evolved from essential thrombocytemia.
    Gozzetti A; Crupi R; Rondoni M; Daviddi B; Defina M; Bocchia M; Pietrini A; Raspadori D; Lauria F
    Cancer Genet Cytogenet; 2010 Feb; 197(1):84-5. PubMed ID: 20113843
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute myeloid leukaemia with inv(3)(q21q26).
    Wong KF; Wong KH
    Br J Haematol; 2012 Apr; 157(2):158. PubMed ID: 22329694
    [No Abstract]   [Full Text] [Related]  

  • 16. Central diabetes insipidus and inv(3)(q21q26) and monosomy 7 in acute myeloid leukemia.
    Keung YK; Buss D; Powell BL; Pettenati M
    Cancer Genet Cytogenet; 2002 Jul; 136(1):78-81. PubMed ID: 12165457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular remission in PCR-positive acute myeloid leukemia patients with inv(16): role of bone marrow transplantation procedures.
    Martinelli G; Ottaviani E; Testoni N; Visani G; Terragna C; Amabile M; Trabacchi E; Montefusco V; Tura S
    Bone Marrow Transplant; 1999 Sep; 24(6):694-7. PubMed ID: 10490740
    [No Abstract]   [Full Text] [Related]  

  • 18. De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia.
    Hsiao HH; Ito Y; Sashida G; Ohyashiki JH; Ohyashiki K
    Leuk Res; 2005 Nov; 29(11):1247-52. PubMed ID: 16164981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute myeloid leukemia developing in the course of essential thrombocythemia].
    Fernández MC; Gardelegui I; Capote FJ; Gil JL; Muñoz JA
    Sangre (Barc); 1996 Oct; 41(5):405-6. PubMed ID: 9026932
    [No Abstract]   [Full Text] [Related]  

  • 20. Masked inv(3)(q21q26) in a patient with minimally differentiated acute myeloid leukemia.
    Wieser R; Schreiner U; Wollenberg B; Neubauer A; Fonatsch C; Rieder H
    Haematologica; 2001 Feb; 86(2):214-5. PubMed ID: 11224497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.